Europe — EMA
Ovamex (Ganirelix)
Ganirelix, the active ingredient in Ovamex, is a gonadotropin-releasing hormone antagonist presented as a solution for subcutaneous injection use.
Request sourcing
What is Ganirelix?
Ganirelix, the active ingredient in Ovamex, is a gonadotropin-releasing hormone antagonist presented as a solution for subcutaneous injection use. It prevents premature ovulation during assisted reproductive technology cycles in women undergoing in vitro fertilisation.
GNH USA supplies Ovamex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and fertility clinics worldwide.
What is Ganirelix used for?
Ganirelix is used in reproductive medicine to control the hormonal cascade that occurs during controlled ovarian stimulation. - In vitro fertilisation (IVF): Prevents the onset of premature ovulation, allowing optimal egg retrieval. - Intracytoplasmic sperm injection (ICSI) cycles : E ...
What are the side effects of Ganirelix?
Common ...
What precautions apply to Ganirelix?
...
What does Ganirelix interact with?
....
